Kv1.3 channel blockers (Wyeth)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameKv1.3 channel blockers (Wyeth)
Drug Alias NameKv1.3 blockers (Wyeth)CPD-554CPD-553
ClassificationSmall molecules
Mechanisms of ActionVoltage-gated potassium channel subunit Kv1.3 blockersImmunomodulators
TargetsVoltage-gated potassium channel subunit Kv1.3
Therapy Area/IndicationsAutoimmune Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesWyeth Llc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesWyeth Llc
Active IndicationsN/A
Inactive IndicationsAutoimmune Diseases

Other Information

ATC CodeN/A
Related LinksN/A